Education
About Us
Working with TipRanks
Follow Us
Modus Therapeutics Holding AB (DE:99Z)
FRANKFURT:99Z
Total Valuation
Modus Therapeutics Holding AB has a market cap or net worth of €4.28M. The enterprise value is €60.49M.
Market Cap€4.28M
Enterprise Value€60.49M
Share Statistics
Modus Therapeutics Holding AB has 35,938,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,938,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Modus Therapeutics Holding AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-8.95M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Modus Therapeutics Holding AB is -1.73. Modus Therapeutics Holding AB’s PEG ratio is 0.15.
PE Ratio-1.73
PS Ratio0.00
PB Ratio1.75
Price to Fair Value1.75
Price to FCF-1.85
Price to Operating Cash Flow-1.85
PEG Ratio0.15
Income Statement
In the last 12 months, Modus Therapeutics Holding AB had revenue of 0.00 and earned -17.90M in profits. Earnings per share was -1.01.
Revenue0.00
Gross Profit0.00
Operating Income-16.40M
Pretax Income-17.90M
Net Income-17.90M
EBITDA2.00K
Earnings Per Share (EPS)-1.01
Cash Flow
In the last 12 months, operating cash flow was -14.19M and capital expenditures 0.00, giving a free cash flow of -14.19M billion.
Operating Cash Flow-14.19M
Free Cash Flow-14.19M
Free Cash Flow per Share-0.39
Dividends & Yields
Modus Therapeutics Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.57
52-Week Price Change42.86%
50-Day Moving Average0.10
200-Day Moving Average0.12
Relative Strength Index (RSI)54.48
Average Volume (3m)333.00
Important Dates
Modus Therapeutics Holding AB upcoming earnings date is May 20, 2025, TBA Not Confirmed.
Last Earnings DateFeb 20, 2025
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
Modus Therapeutics Holding AB as a current ratio of 8.47, with Debt / Equity ratio of 0.00%
Current Ratio8.47
Quick Ratio8.47
Debt to Market Cap0.00
Net Debt to EBITDA―
Interest Coverage Ratio-10.96
Taxes
In the past 12 months, Modus Therapeutics Holding AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Modus Therapeutics Holding AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Modus Therapeutics Holding AB has €8.00M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€8.00M billion.
Cash & Marketable Securities€8.00M
Total Debtkr0.00
Net Cash-€8.00M
Net Cash Per Share-€0.22
Tangible Book Value Per Share€1.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Modus Therapeutics Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―